Braveheart files amended charter authorizing additional common stock

Braveheart Bio filed its second amended and restated certificate of incorporation, increasing its authorized common stock to 500 million shares and eliminating existing preferred stock designs. Filings are typically driven by capital structure changes needed for future corporate moves.